ROP:SWX
Roche Holding AG Genussscheine
CHFÂ 347.70
0.00%
(0.00) 1D
Sep 9, 5:31:24 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Mkt. cap
282.09B
Avg. vol.
868.12K
Volume
0.00
Dividend
2.82%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
22.69
52-wk high
CHFÂ 375.80
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
Mkt. cap
282.09B
Avg. vol.
868.12K
Volume
0.00
Dividend
2.82%
Quarterly dividend
CHFÂ 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
22.69
52-wk high
CHFÂ 375.80
52-wk low
CHFÂ 291.00
EPS
CHFÂ 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Roche Holding stock heads into the open after a 0.8 percent drop
Stock Titan
·
2 hours ago
A drug cut relapse risk by 68% in a rare nerve disease with no approved treatment
Investing.com
·
20 hours ago
RBC Capital initiates Roche stock with outperform rating on pipeline potential
marketscreener.com
·
1 day ago
RBC Starts Roche Coverage at Outperform on Base Business Improvement, 'Underappreciated' Pipeline
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com